Corrigendum to 'IMscin001 Part 2: a randomised phase III, open-label, multicentre study examining the pharmacokinetics, efficacy, immunogenicity, and safety of atezolizumab subcutaneous versus intravenous administration in previously treated locally advanced or metastatic non-small-cell lung cancer and pharmacokinetics comparison with other approved indications': [Annals of Oncology 34 (2023) p693-702].

Burotto, M; Zvirbule, Z; Mochalova, A; Runglodvatana, Y; Herraez-Baranda, L; Liu, S N; Chan, P; Shearer-Kang, E; Liu, X; Tosti, N; Zanghi, J A; Leutgeb, B; Felip, E

Burotto, M; Zvirbule, Z; Mochalova, A; Runglodvatana, Y; Herraez-Baranda, L; Liu, S N; Chan, P; Shearer-Kang, E; Liu, X; Tosti, N; Zanghi, J A; Leutgeb, B; Felip, E.

Afiliação

Burotto M; Centro de Investigación, Clínica Bradford Hill, Santiago, Chile. Electronic address: Mburotto@bradfordhill.cl.
Zvirbule Z; Latvian Oncology Center, Riga Eastern Clinical University Hospital, Riga, Latvia.
Mochalova A; Department of Antitumor Drug Therapy, MEDSI Clinical Hospital, Moscow, Russia.
Runglodvatana Y; Faculty of Medicine, Vajira Hospital, Bangkok Metropolitan University, Bangkok, Thailand.
Herraez-Baranda L; Product Development Medical Affairs Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Liu SN; Clinical Pharmacology, Genentech, Inc., South San Francisco, USA.
Chan P; Clinical Pharmacology, Genentech, Inc., South San Francisco, USA.
Shearer-Kang E; Product Safety Development, Genentech, Inc., South San Francisco, CA, USA.
Liu X; Data and Statistical Sciences, Genentech, Inc., South San Francisco, CA, USA.
Tosti N; Product Development Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Zanghi JA; BioAnalytical Sciences, Genentech, Inc., South San Francisco, CA, USA.
Leutgeb B; Product Development Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Felip E; Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Clinical Research Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain.

Ann Oncol ; 35(5): 482, 2024 May.

Article em En | MEDLINE | ID: mdl-38195363

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google